Pharmeasy is speculated to raise 400 million during its IPO lin October, putting it at a valuation of USD 5.4 billion.
Healthtech behemoth Pharmeasy has appointed five new independent directors ahead of its IPO in October. The parent company of Pharmeasy, API holdings said the new people in the leadership position will bring diversity to the board. The new appointees come from diverse fields like medicine, technology, public service, among others.
The new appointees to the board include ex CFO of Titan Company Subramanian Somasundaram, Mumbai-based gynecologist Dr Jaydeep Tank, Ex-Revenue Secretary of India, Vineeta Rai, Founder and COO Livspace Ramakant Sharma, and Deepak Vaidya. The appointments will help integrate medical care with different fields of the economy.
Pharmeasy is speculated to raise 400 million during its IPO lin October, putting it at a valuation of USD 5.4 billion. The unicorn had recently announced the acquisition of Thryrocare in a massive INR 4,500 crore deal, making it the largest acquisition thus far in the health-tech space.
Source: Business World
